Role of zinc and copper has been studied
extensively in health and disease. Zinc is necessary for optimum
performance of immune function and deficiency results in increased
morbidity due to infections especially gastrointestinal and respiratory
[1, 2]. Alterations in serum levels of zinc and copper have also been
studied in several malignant and lymphoproliferative disorders [3, 4].
There are no studies in patients with aplastic anemia. Aim of this
study was to evaluate the serum levels of zinc and copper in pediatric
patients with idiopathic aplastic anemia at the time of diagnosis and to
correlate the levels with severity of disease.
45 patients with newly diagnosed idiopathic aplastic
anemia in the age group of 4 to 15 years admitted in pediatric ward over
18 months were included in the study. Inclusion criteria were: at least
two of the following (i) hemoglobin <10 g/L (ii) platelet
count <50 ×10
Our results demonstrated significantly low levels of
serum zinc in patients with aplastic anemia which correlated with
disease severity. Zinc deficiency may further compromise the low
immunity seen in these patients as zinc plays a vital role in immune
function. Similar trend was seen for copper zinc ratio. We also observed
increased serum levels of copper in the patients although the levels did
not correlate with severity of disease. Similar alterations and an
inverse relationship between zinc and copper levels have been previously
observed in childhood leukaemia and lymphoma where they have been used
to monitor the disease severity and relapse [7]. Increased uptake of
zinc from serum because of increased metabolism has been suggested as a
possible mechanism for low zinc levels [8]. Similar mechanisms may be
operative in patients with aplastic anemia but needs more investigation.
This is a new area of research and there are no other studies to make a
comparative analysis of our results. Correlation with treatment outcome
would be an interesting application of this study.
Contributors: VG designed the study and prepared
the manuscript. AK collected the data and searched the literature. RKA
helped in the analysis of samples.
Funding: None; Competing interests: None
stated.
References
1. Rink L, Haase H. Zinc homeostasis and immunity.
Trends Immunol. 2007;28:1-4.
2. Yakoob MY, Theodoratou E, Jabeen A, Imdad A,
Eisele TP, Ferguson J, et al. Preventive zinc supplementation in
developing countries: impact on mortality and morbidity due to
diarrhoea, pneumonia and malaria. BMC Public Health. 2011;3:S23.
3. Gupta SK, Shukla VK, Gupta V, Gupta S. Serum trace
elements and Cu/Zn ratio in malignant lymphomas in children. J Trop
Pediatr. 1994;40:185-7.
4. Alexander FW, Delves HT, Lay H. Plasma copper and
zinc in acute leukaemia. Arch Dis Child. 1972;47:671.
5. International Agranulocytosis and Aplastic Anaemia
study. Incidence of aplastic anemia: relevance of diagnostic criteria.
Blood. 1987;70:1718-21.
6. Camitta BM, Rappeport JM, Parkman R, Nathan, DG.
Selection of patients for bone marrow transplantation in severe aplastic
anemia. Blood. 1975;45:355-63.
7. Tessmer CF, Hrgovcic M, Wilbur J. Serum copper in
Hodgkin’s disease in children. Cancer. 1973;31:303-15.
8. Delves HT, Clayton BE, Bicknell J. Concentration of
trace metals in the blood of children. Br J Prev Soc Med. 1973;27:100-7.